Patent granted for identifying deoxyribonucleic acid (DNA) samples:
This article was originally published in Clinica
Canadian company Visible Genetics has received a US patent for a method for identifying DNA samples. The patent covers tubes containing unique "identification DNA" and matching bar code labels on the same tube. At any stage of blood testing, the identity of the patient can be confirmed by sequencing the identification DNA.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.